SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of White River Capital, Inc. (RVR), BioMimetic Therapeutics Inc. (BMTI) , Jeffries Group, Inc. (JEF) and Provectus Pharmaceuticals, Inc. (PVCT)

NEW YORK, Nov. 21, 2012 /PRNewswire/ --  

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

White River Capital, Inc.
Levi & Korsinsky is investigating the Board of Directors of White River Capital, Inc. (NYSE MKT: RVR) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company and its subsidiary, Coastal Credit, LLC, to an affiliate of Parthenon Capital Partners for $23 per share.

Click here to learn more about the investigation http://zlk.9nl.com/white-river-capital-rvr.  

BioMimetic Therapeutics Inc.
Levi & Korsinsky is investigating the Board of Directors of BioMimetic Therapeutics Inc. BMTI for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Wright Medical Group Inc. WMGI under which shareholders BioMimetic shareholders will receive $1.50 in cash and 0.2482 shares of Wright common stock for each share of BioMimetic stock they own.

Click here to learn more about the investigation http://zlk.9nl.com/biomimetic-bmti.  

Jeffries Group, Inc.
Levi & Korsinsky is investigating the Board of Directors of Jeffries Group, Inc. JEF for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to its largest shareholder, Leucadia National Corp. LUK under which shareholders will receive 0.81 Leucadia shares for each share of Jefferies stock they own, representing an approximate value of $17.24 per share. At least one analyst set a price target of $19.00 per Jefferies share.

Click here to learn more about the investigation http://zlk.9nl.com/jefferies-group-jef, or call: 877-363-5972.

Provectus Pharmaceuticals, Inc.
Levi & Korsinsky, LLP is investigating Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), and its Board of Directors in connection with the compensation provided to certain of its executive officers.

To get more information, click here: http://zlk.9nl.com/provectus-pharmaceuticals-pvct, or call: 877-363-5972

Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP